EIF2A and chronic myelogenous leukemia, BCR-ABL1 positive: However, ER stress-induced upregulation of the PERK-eIF2a phosphorylation pathway was shown to be associated with imatinib resistance in CML cell lines and CD34+ cells from CML patients [25].